or Try an Advanced Search...

    Technical Analysis for OKUR - OnKure Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 17.95 -3.44% -0.64
    OKUR closed down 3.44 percent on Thursday, October 17, 2024, on 2.42 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical OKUR trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Gapped Down Weakness 0.00%
    NR7 Range Contraction -3.44%
    Narrow Range Bar Range Contraction -3.44%
    Inside Day Range Contraction -3.44%
    Wide Bands Range Expansion -3.44%
    Overbought Stochastic Strength -3.44%
    Stochastic Sell Signal Bearish -4.27%
    Volume Surge Other -4.27%
    Older End-of-Day Signals for OKUR ...

       Recent Intraday Alerts

    Alert Time
    10x Volume Pace about 18 hours ago
    5x Volume Pace about 18 hours ago
    Down 1 ATR about 18 hours ago
    10 DMA Resistance about 19 hours ago
    2x Volume Pace about 19 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    OKUR Chart by TradingView
    Basic chart:

    Profile

    OnKure is a clinical-stage biopharmaceutical company focused on the discovery and development of best-in-class precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. Using a structure-based drug design platform, OnKure is building a robust pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability. OnKure is currently developing OKI-219, a selective PI3KαH1047R inhibitor, as its lead program. OnKure aims to become a leader in targeting oncogenic PI3Kα and has multiple programs designed to enable best-in-class targeting of this key oncogene.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Personalized Medicine Drug Design

    Is OKUR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 10 OnKure started at outperform by Oppenheimer, OKI-219 potential cited
    Oct 7 OnKure and Reneo Pharmaceuticals complete merger
    Oct 4 OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million
    Oct 3 Reneo stockholders approve merger with OnKure
    Oct 3 Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure
    Aug 13 Reneo Pharmaceuticals GAAP EPS of -$0.16
    Aug 13 Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results
    May 17 Reneo Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying
    May 13 Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise
    May 13 Reneo Pharmaceuticals gains on deal to merge with OnKure
    See more OKUR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 86.7
    52 Week Low 9.801
    Average Volume 29,218
    200-Day Moving Average 16.18
    50-Day Moving Average 15.48
    20-Day Moving Average 16.86
    10-Day Moving Average 18.19
    Average True Range 1.23
    RSI (14) 45.05
    ADX 28.6
    +DI 5.90
    -DI 25.04
    Chandelier Exit (Long, 3 ATRs) 15.57
    Chandelier Exit (Short, 3 ATRs) 16.39
    Upper Bollinger Bands 20.11
    Lower Bollinger Band 13.60
    Percent B (%b) 0.67
    BandWidth 38.61
    MACD Line 1.01
    MACD Signal Line 0.89
    MACD Histogram 0.1174
    Fundamentals Value
    Market Cap 597.95 Million
    Num Shares 33.3 Million
    EPS -2.36
    Price-to-Earnings (P/E) Ratio -7.61
    Price-to-Sales 0.00
    Price-to-Book 0.48
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 20.12
    Resistance 3 (R3) 20.02 19.20 19.76
    Resistance 2 (R2) 19.20 18.65 19.25 19.64
    Resistance 1 (R1) 18.57 18.30 18.16 18.67 19.52
    Pivot Point 17.75 17.75 17.55 17.80 17.75
    Support 1 (S1) 17.13 17.20 16.72 17.23 16.38
    Support 2 (S2) 16.31 16.86 16.36 16.26
    Support 3 (S3) 15.68 16.31 16.14
    Support 4 (S4) 15.78